BrandonMcmahonBrandon J Mcmahon39.74273230000000-104.8391914000000011837Mcmahon, BrandonJ720/848-8868Associate ProfessorFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:orcidIdORCID idvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonTylerBucknerTyler W. Buckner39.74273230000000-104.839191400000009601Buckner, TylerAssociate ProfessorErinFahey-HarrisonErin Fahey-Harrison39.74273230000000-104.8391914000000011305Fahey-Harrison, ErinSenior Instructor1665 Aurora Court2FACPAnschutz Cancer Pavilion1665 Aurora CourtAurora80045-0580CO1.459710.00916966228research areas20.78943.2138960similar to1135selected publicationsAuthorship 1462783Authorship 1464852Authorship 1465092Authorship 1465282Authorship 1465291Authorship 1465462Authorship 1466111Authorship 14662511Authorship 1466261Authorship 1466281Authorship 1466457Authorship 14665310Authorship 1466691Authorship 1466765Authorship 1466778Authorship 1466863Authorship 1466892Authorship 1467172Authorship 1467327Authorship 1467449Authorship 1467613Authorship 1467631Authorship 1467711Authorship 1467795Authorship 1467936Authorship 1468931Authorship 1468945Authorship 146904223350890McMahon BLeukemia & lymphomaMcMahon B. Heterogeneity in the myelodysplastic syndromes: moving toward a better understanding. Leuk Lymphoma. 2013 May; 54(5):907-8.Leuk Lymphoma2013-02-05T00:00:002013Heterogeneity in the myelodysplastic syndromes: moving toward a better understanding.25151525McMahon BJ, Kwaan HCSeminars in thrombosis and hemostasisMcMahon BJ, Kwaan HC. Thrombocytopenia in older adults. Semin Thromb Hemost. 2014 Sep; 40(6):682-7.Semin Thromb Hemost2014-08-24T00:00:002014Thrombocytopenia in older adults.25152988Martin K, Kia L, Parikh ND, Kulik L, McMahon BAnnals of hepatologyMartin K, Kia L, Parikh ND, Kulik L, McMahon B. Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes. Ann Hepatol. 2014 Sep-Oct; 13(5):548-54.Ann Hepatol2014-09-01T00:00:002014Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes.27043813Buck RJ, Wachsberg KN, Weaver AC, Hansen LO, McMahon BJ, Dombrowski L, O'Leary KJSouthern medical journalBuck RJ, Wachsberg KN, Weaver AC, Hansen LO, McMahon BJ, Dombrowski L, O'Leary KJ. Survey of Provider Transfusion Practices for Oncology Patients in an Academic Medical Center. South Med J. 2016 Apr; 109(4):267-71.South Med J2016-04-01T00:00:002016Survey of Provider Transfusion Practices for Oncology Patients in an Academic Medical Center.18854275Green D, McMahon B, Foiles N, Tian LAmerican journal of clinical pathologyGreen D, McMahon B, Foiles N, Tian L. Measurement of hemostatic factors in EDTA plasma. Am J Clin Pathol. 2008 Nov; 130(5):811-5.Am J Clin Pathol2008-11-01T00:00:002008Measurement of hemostatic factors in EDTA plasma.27092833McMahon B, Kamath SJAMAMcMahon B, Kamath S. Pancytopenia in a Patient With Hypothyroidism. JAMA. 2016 Apr 19; 315(15):1648-9.JAMA2016-04-19T00:00:002016Pancytopenia in a Patient With Hypothyroidism.25259875Kwaan HC, McMahon BJ, Hylek EMSeminars in thrombosis and hemostasisKwaan HC, McMahon BJ, Hylek EM. Age-related changes in thrombosis and hemostasis. Semin Thromb Hemost. 2014 Sep; 40(6):619-20.Semin Thromb Hemost2014-09-26T00:00:002014Age-related changes in thrombosis and hemostasis.23532574Kwaan HC, Mazar AP, McMahon BJSeminars in thrombosis and hemostasisKwaan HC, Mazar AP, McMahon BJ. The apparent uPA/PAI-1 paradox in cancer: more than meets the eye. Semin Thromb Hemost. 2013 Jun; 39(4):382-91.Semin Thromb Hemost2013-03-26T00:00:002013The apparent uPA/PAI-1 paradox in cancer: more than meets the eye.24469448Kaur S, Kroczynska B, Sharma B, Sassano A, Arslan AD, Majchrzak-Kita B, Stein BL, McMahon B, Altman JK, Su B, Calogero RA, Fish EN, Platanias LCThe Journal of biological chemistryKaur S, Kroczynska B, Sharma B, Sassano A, Arslan AD, Majchrzak-Kita B, Stein BL, McMahon B, Altman JK, Su B, Calogero RA, Fish EN, Platanias LC. Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses. J Biol Chem. 2014 Mar 07; 289(10):6581-6591.J Biol Chem2014-01-27T00:00:002014Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses.27247481Kamath SD, McMahon BJSeminars in interventional radiologyKamath SD, McMahon BJ. Update on Anticoagulation: What the Interventional Radiologist Needs to Know. Semin Intervent Radiol. 2016 Jun; 33(2):122-31.Semin Intervent Radiol2016-06-01T00:00:002016Update on Anticoagulation: What the Interventional Radiologist Needs to Know.11859187Scott LT, Boorum MM, McMahon BJ, Hagen S, Mack J, Blank J, Wegner H, de Meijere AScience (New York, N.Y.)Scott LT, Boorum MM, McMahon BJ, Hagen S, Mack J, Blank J, Wegner H, de Meijere A. A rational chemical synthesis of C60. Science. 2002 Feb 22; 295(5559):1500-3.Science2002-02-22T00:00:002002A rational chemical synthesis of C60.19097173Ruch J, McMahon B, Ramsey G, Kwaan HCAmerican journal of hematologyRuch J, McMahon B, Ramsey G, Kwaan HC. Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol. 2009 Feb; 84(2):120-2.Am J Hematol2009-02-01T00:00:002009Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab.19176991McMahon B, Kwaan HCPathophysiology of haemostasis and thrombosisMcMahon B, Kwaan HC. The plasminogen activator system and cancer. Pathophysiol Haemost Thromb. 2008; 36(3-4):184-94.Pathophysiol Haemost Thromb2009-01-27T00:00:002009The plasminogen activator system and cancer.26440973Kander EM, Raza S, Zhou Z, Gao J, Zakarija A, McMahon BJ, Stein BLInternational journal of hematologyKander EM, Raza S, Zhou Z, Gao J, Zakarija A, McMahon BJ, Stein BL. Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort. Int J Hematol. 2015 Nov; 102(5):587-93.Int J Hematol2015-10-06T00:00:002015Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort.19285282Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MSBest practice & research. Clinical haematologyStein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol. 2009 Mar; 22(1):153-63.Best Pract Res Clin Haematol2009-03-01T00:00:002009The coagulopathy of acute promyelocytic leukaemia revisited.23814052Mehrotra S, Sharma B, Joshi S, Kroczynska B, Majchrzak B, Stein BL, McMahon B, Altman JK, Licht JD, Baker DP, Eklund EA, Wickrema A, Verma A, Fish EN, Platanias LCThe Journal of biological chemistryMehrotra S, Sharma B, Joshi S, Kroczynska B, Majchrzak B, Stein BL, McMahon B, Altman JK, Licht JD, Baker DP, Eklund EA, Wickrema A, Verma A, Fish EN, Platanias LC. Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors. J Biol Chem. 2013 Aug 16; 288(33):23814-22.J Biol Chem2013-06-28T00:00:002013Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.23055392McMahon BJ, Kwaan HCSeminars in thrombosis and hemostasisMcMahon BJ, Kwaan HC. Thrombotic and bleeding complications associated with chemotherapy. Semin Thromb Hemost. 2012 Nov; 38(8):808-17.Semin Thromb Hemost2012-10-10T00:00:002012Thrombotic and bleeding complications associated with chemotherapy.23074222Sharma B, Joshi S, Sassano A, Majchrzak B, Kaur S, Aggarwal P, Nabet B, Bulic M, Stein BL, McMahon B, Baker DP, Fukunaga R, Altman JK, Licht JD, Fish EN, Platanias LCThe Journal of biological chemistrySharma B, Joshi S, Sassano A, Majchrzak B, Kaur S, Aggarwal P, Nabet B, Bulic M, Stein BL, McMahon B, Baker DP, Fukunaga R, Altman JK, Licht JD, Fish EN, Platanias LC. Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses. J Biol Chem. 2012 Dec 07; 287(50):42352-60.J Biol Chem2012-10-16T00:00:002012Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses.26530365McMahon BJ, Kwaan HCAdvances in experimental medicine and biologyMcMahon BJ, Kwaan HC. Components of the Plasminogen-Plasmin System as Biologic Markers for Cancer. Adv Exp Med Biol. 2015; 867:145-56.Adv Exp Med Biol2015-01-01T00:00:002015Components of the Plasminogen-Plasmin System as Biologic Markers for Cancer.19377918Kwaan HC, McMahon BCancer treatment and researchKwaan HC, McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat Res. 2009; 148:43-66.Cancer Treat Res2009-01-01T00:00:002009The role of plasminogen-plasmin system in cancer.26543644Yentz S, Onwuemene OA, Stein BL, Cull EH, McMahon BThrombosisYentz S, Onwuemene OA, Stein BL, Cull EH, McMahon B. Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis. Thrombosis. 2015; 2015:126975.Thrombosis2015-10-12T00:00:002015Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis.25680924Prince BT, McMahon BJ, Jain M, Peters ATThe journal of allergy and clinical immunology. In practicePrince BT, McMahon BJ, Jain M, Peters AT. Meropenem tolerance in a patient with probable fulminant piperacillin-induced immune hemolytic anemia. J Allergy Clin Immunol Pract. 2015 May-Jun; 3(3):452-3.J Allergy Clin Immunol Pract2015-02-11T00:00:002015Meropenem tolerance in a patient with probable fulminant piperacillin-induced immune hemolytic anemia.25682082McMahon BJ, Kwaan HCSeminars in thrombosis and hemostasisMcMahon BJ, Kwaan HC. The new or non-vitamin K antagonist oral anticoagulants: what have we learned since their debut. Semin Thromb Hemost. 2015 Mar; 41(2):188-94.Semin Thromb Hemost2015-02-15T00:00:002015The new or non-vitamin K antagonist oral anticoagulants: what have we learned since their debut.23245211Stein BL, Saraf S, Sobol U, Halpern A, Shammo J, Rondelli D, Michaelis L, Odenike O, Rademaker A, Zakarija A, McMahon B, Spivak JL, Moliterno ARLeukemia & lymphomaStein BL, Saraf S, Sobol U, Halpern A, Shammo J, Rondelli D, Michaelis L, Odenike O, Rademaker A, Zakarija A, McMahon B, Spivak JL, Moliterno AR. Age-related differences in disease characteristics and clinical outcomes in polycythemia vera. Leuk Lymphoma. 2013 Sep; 54(9):1989-95.Leuk Lymphoma2013-01-08T00:00:002013Age-related differences in disease characteristics and clinical outcomes in polycythemia vera.23264112McMahon B, Stein BLSeminars in thrombosis and hemostasisMcMahon B, Stein BL. Thrombotic and bleeding complications in classical myeloproliferative neoplasms. Semin Thromb Hemost. 2013 Feb; 39(1):101-11.Semin Thromb Hemost2012-12-23T00:00:002012Thrombotic and bleeding complications in classical myeloproliferative neoplasms.25892232Saleiro D, Mehrotra S, Kroczynska B, Beauchamp EM, Lisowski P, Majchrzak-Kita B, Bhagat TD, Stein BL, McMahon B, Altman JK, Kosciuczuk EM, Baker DP, Jie C, Jafari N, Thompson CB, Levine RL, Fish EN, Verma AK, Platanias LCCell reportsSaleiro D, Mehrotra S, Kroczynska B, Beauchamp EM, Lisowski P, Majchrzak-Kita B, Bhagat TD, Stein BL, McMahon B, Altman JK, Kosciuczuk EM, Baker DP, Jie C, Jafari N, Thompson CB, Levine RL, Fish EN, Verma AK, Platanias LC. Central role of ULK1 in type I interferon signaling. Cell Rep. 2015 Apr 28; 11(4):605-17.Cell Rep2015-04-16T00:00:002015Central role of ULK1 in type I interferon signaling.25049393Kroczynska B, Mehrotra S, Majchrzak-Kita B, Arslan AD, Altman JK, Stein BL, McMahon B, Kozlowski P, Kahle PJ, Eklund EA, Fish EN, Platanias LCProceedings of the National Academy of Sciences of the United States of AmericaKroczynska B, Mehrotra S, Majchrzak-Kita B, Arslan AD, Altman JK, Stein BL, McMahon B, Kozlowski P, Kahle PJ, Eklund EA, Fish EN, Platanias LC. Regulatory effects of SKAR in interferon a signaling and its role in the generation of type I IFN responses. Proc Natl Acad Sci U S A. 2014 Aug 05; 111(31):11377-82.Proc Natl Acad Sci U S A2014-07-21T00:00:002014Regulatory effects of SKAR in interferon a signaling and its role in the generation of type I IFN responses.26870834Kaplan JB, Stein BL, McMahon B, Giles FJ, Platanias LCEBioMedicineKaplan JB, Stein BL, McMahon B, Giles FJ, Platanias LC. Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms. EBioMedicine. 2016 Jan; 3:17-25.EBioMedicine2016-01-13T00:00:002016Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms.JessicaZuckerJessica G Zucker39.74273230000000-104.8391914000000011971Zucker, JessicaSenior Instructor1Professor2Assoc Professor4InstructorAuthorship 158574727558575Waisbren J, Dinner S, Altman J, Frankfurt O, Helenowski I, Gao J, McMahon BJ, Stein BLInternational journal of hematologyWaisbren J, Dinner S, Altman J, Frankfurt O, Helenowski I, Gao J, McMahon BJ, Stein BL. Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia. Int J Hematol. 2017 Jan; 105(1):44-51.Int J Hematol2016-08-24T00:00:002016Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia.Authorship 1706791128982745Mesa RA, Jamieson C, Bhatia R, Deininger MW, Fletcher CD, Gerds AT, Gojo I, Gotlib J, Gundabolu K, Hobbs G, McMahon B, Mohan SR, Oh S, Padron E, Papadantonakis N, Pancari P, Podoltsev N, Rampal R, Ranheim E, Reddy V, Rein LAM, Scott B, Snyder DS, Stein BL, Talpaz M, Verstovsek S, Wadleigh M, Wang ES, Bergman MA, Gregory KM, Sundar HJournal of the National Comprehensive Cancer Network : JNCCNMesa RA, Jamieson C, Bhatia R, Deininger MW, Fletcher CD, Gerds AT, Gojo I, Gotlib J, Gundabolu K, Hobbs G, McMahon B, Mohan SR, Oh S, Padron E, Papadantonakis N, Pancari P, Podoltsev N, Rampal R, Ranheim E, Reddy V, Rein LAM, Scott B, Snyder DS, Stein BL, Talpaz M, Verstovsek S, Wadleigh M, Wang ES, Bergman MA, Gregory KM, Sundar H. NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018. J Natl Compr Canc Netw. 2017 10; 15(10):1193-1207.J Natl Compr Canc Netw2017-10-01T00:00:002017NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018.MarcBonacaMarc Peter Bonaca39.74801570000000-104.8344263000000014508Bonaca, MarcProfessorAuthorship 1911341730442731Streiff MB, Holmstrom B, Angelini D, Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Hendrie P, Lee AI, Lee JT, Mann J, McMahon B, Millenson MM, Morton C, Ortel TL, Ozair S, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Williams E, Zakarija A, Hammond L, Dwyer MA, Engh AMJournal of the National Comprehensive Cancer Network : JNCCNStreiff MB, Holmstrom B, Angelini D, Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Hendrie P, Lee AI, Lee JT, Mann J, McMahon B, Millenson MM, Morton C, Ortel TL, Ozair S, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Williams E, Zakarija A, Hammond L, Dwyer MA, Engh AM. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018 11; 16(11):1289-1303.J Natl Compr Canc Netw2018-11-01T00:00:002018NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.Authorship 1923521030545997Gotlib J, Gerds AT, Bose P, Castells MC, Deininger MW, Gojo I, Gundabolu K, Hobbs G, Jamieson C, McMahon B, Mohan SR, Oehler V, Oh S, Padron E, Pancari P, Papadantonakis N, Pardanani A, Podoltsev N, Rampal R, Ranheim E, Rein L, Snyder DS, Stein BL, Talpaz M, Thota S, Wadleigh M, Walsh K, Bergman MA, Sundar HJournal of the National Comprehensive Cancer Network : JNCCNGotlib J, Gerds AT, Bose P, Castells MC, Deininger MW, Gojo I, Gundabolu K, Hobbs G, Jamieson C, McMahon B, Mohan SR, Oehler V, Oh S, Padron E, Pancari P, Papadantonakis N, Pardanani A, Podoltsev N, Rampal R, Ranheim E, Rein L, Snyder DS, Stein BL, Talpaz M, Thota S, Wadleigh M, Walsh K, Bergman MA, Sundar H. Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 12; 16(12):1500-1537.J Natl Compr Canc Netw2018-12-01T00:00:002018Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.D013921Disorders1191880.841372ThrombocytopeniaKeithNeevesKeith Benjamin Neeves39.73010690000000-104.9378820000000015224Neeves, Keith0000-0001-7546-4588ProfessorD017395Chemicals & Drugs54840.954327Plasminogen Activator Inhibitor 1D009196Disorders19270.968705Myeloproliferative DisordersD014568Chemicals & Drugs24300.98166Urokinase-Type Plasminogen ActivatorCEDC-BioengineeringONC GENERAL OPERATIONSD013927AnatomyDisorders1673190.760068ThrombosisSOM-MEDSOM-PEDSHematologyOncBoneMarrow TransplantCardiologyUniversity of Colorado Denver - Anschutz Medical CampusDavidCamidgeDavid Ross Camidge39.74273230000000-104.839191400000002375Camidge, DavidProfessorBenjaminBrewerBenjamin W Brewer39.74273230000000-104.839191400000003874Brewer, BenjaminAssociate ProfessorChristopherSillimanChristopher Silliman39.74403510000000-104.83605940000000667Silliman, ChristopherProfessorKeriHalsemaKeri Halsema39.74273230000000-104.839191400000007728Halsema, KeriSenior InstructorAuthorship 216733532089887Shaikh SS, Kamath SD, Ghosh D, Lewandowski RJ, McMahon BJInternational journal of vascular medicineShaikh SS, Kamath SD, Ghosh D, Lewandowski RJ, McMahon BJ. Safety and Outcomes of Permanent and Retrievable Inferior Vena Cava Filters in the Oncology Population. Int J Vasc Med. 2020; 2020:6582742.Int J Vasc Med2020-02-05T00:00:002020Safety and Outcomes of Permanent and Retrievable Inferior Vena Cava Filters in the Oncology Population.Authorship 2267161532886902Gerds AT, Gotlib J, Bose P, Deininger MW, Dunbar A, Elshoury A, George TI, Gojo I, Gundabolu K, Hexner E, Hobbs G, Jain T, Jamieson C, Kuykendall AT, McMahon B, Mohan SR, Oehler V, Oh S, Pardanani A, Podoltsev N, Ranheim E, Rein L, Salit R, Snyder DS, Stein BL, Talpaz M, Thota S, Vachhani P, Wadleigh M, Walsh K, Ward DC, Bergman MA, Sundar HJournal of the National Comprehensive Cancer Network : JNCCNGerds AT, Gotlib J, Bose P, Deininger MW, Dunbar A, Elshoury A, George TI, Gojo I, Gundabolu K, Hexner E, Hobbs G, Jain T, Jamieson C, Kuykendall AT, McMahon B, Mohan SR, Oehler V, Oh S, Pardanani A, Podoltsev N, Ranheim E, Rein L, Salit R, Snyder DS, Stein BL, Talpaz M, Thota S, Vachhani P, Wadleigh M, Walsh K, Ward DC, Bergman MA, Sundar H. Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 09; 18(9):1248-1269.J Natl Compr Canc Netw2020-09-01T00:00:002020Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.ScottBerkowitzScott Darrell Berkowitz19131Berkowitz, ScottProfessor-ClinicalAuthorship 2714921636075392Gerds AT, Gotlib J, Ali H, Bose P, Dunbar A, Elshoury A, George TI, Gundabolu K, Hexner E, Hobbs GS, Jain T, Jamieson C, Kaesberg PR, Kuykendall AT, Madanat Y, McMahon B, Mohan SR, Nadiminti KV, Oh S, Pardanani A, Podoltsev N, Rein L, Salit R, Stein BL, Talpaz M, Vachhani P, Wadleigh M, Wall S, Ward DC, Bergman MA, Hochstetler CJournal of the National Comprehensive Cancer Network : JNCCNGerds AT, Gotlib J, Ali H, Bose P, Dunbar A, Elshoury A, George TI, Gundabolu K, Hexner E, Hobbs GS, Jain T, Jamieson C, Kaesberg PR, Kuykendall AT, Madanat Y, McMahon B, Mohan SR, Nadiminti KV, Oh S, Pardanani A, Podoltsev N, Rein L, Salit R, Stein BL, Talpaz M, Vachhani P, Wadleigh M, Wall S, Ward DC, Bergman MA, Hochstetler C. Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 09; 20(9):1033-1062.J Natl Compr Canc Netw2022-09-01T00:00:002022Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1Senior InstructorSenior Instructortrue1Senior InstructorSenior Instructortrue1Professor-ClinicalProfessor-Clinicaltrue1Senior InstructorSenior Instructortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor